Wallace Advisory Group’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$258K Sell
2,182
-1,293
-37% -$160K 0.28% 101
2025
Q4
$437K Sell
3,475
-2,081
-37% -$271K 0.46% 52
2025
Q3
$866K Sell
5,556
-1,503
-21% -$227K 0.7% 36
2025
Q2
$1.16M Buy
7,059
+1,422
+25% +$225K 0.84% 33
2025
Q1
$918K Buy
5,637
+1,194
+27% +$199K 0.64% 40
2024
Q4
$868K Buy
4,443
+48
+1% +$8.58K 0.6% 43
2024
Q3
$762K Sell
4,395
-81
-2% -$14.9K 0.56% 41
2024
Q2
$776K Buy
4,476
+1,228
+38% +$204K 0.56% 41
2024
Q1
$641K Buy
3,248
+38
+1% +$7.12K 0.48% 50
2023
Q4
$558K Sell
3,210
-296
-8% -$52.4K 0.44% 53
2023
Q3
$604K Buy
3,506
+13
+0.4% +$2.36K 0.43% 47
2023
Q2
$581K Hold
3,493
0.44% 52
2023
Q1
$581K Sell
3,493
-49
-1% -$8.03K 0.44% 52
2022
Q4
$519K Buy
+3,542
New +$524K 0.41% 58

Other funds holding ZTS

Wallace Advisory Group's ZTS Position: Q1 2026 in Review

Wallace Advisory Group reduced its Zoetis (ZTS) stake by 37% in Q1 2026, selling an estimated $160K and leaving 2,182 shares worth $258K. The position accounts for 0.28% of the portfolio, ranked #101.

Wallace Advisory Group first reported a position in ZTS in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.16M in Q2 2025. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Wallace Advisory Group held 2,182 shares of Zoetis worth $258K as of Q1 2026.
  • Wallace Advisory Group sold 1,293 Zoetis shares in Q1 2026, an estimated $160K.
  • Zoetis made up 0.28% of Wallace Advisory Group's portfolio in Q1 2026, its #101 holding.
  • Wallace Advisory Group first reported a position in Zoetis in Q4 2022 and has held it in 14 quarters since.
  • Wallace Advisory Group's Zoetis position peaked at $1.16M in Q2 2025.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Wallace Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.